Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Intravenous Efgartigimod 10 Mg/Kg in Adult Patients with Primary Immune Thrombocytopenia: Advance, a Phase 3 Clinical Trial in Progress

Adrian C. Newland, Howard A. Liebman, MD, Vickie McDonald, MD, Marc Michel, Yoshitaka Miyakawa, Wim Parys, MD, Hans De Haard, Peter Ulrichts, Marie Godar, Kristof De Beuf, Jaume Ayguasanosa, Catherine M Broome, David J. Kuter, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-141161

Published: 2020

Journal Articles

Targeting Protein Disulfide Isomerase with the Oral Flavonoid Isoquercetin Prevents Venous Thromboembolism in Advanced Cancer: Results of a Multi-Dose, Multi-Center, Phase II Clinical Trial (CATIQ Study)

Jeffrey I. Zwicker, MD, Benjamin L. Schlechter, MD, Jack Davis Stopa, PhD, Howard A. Liebman, MD, Anita Aggarwal, PhDDO, Thomas Caughey, MD, Ken A. Bauer, MD, Nancy Kuemmerle, D.O., Ellice Y. Wong, MD, Ted Wun, MD, Marilyn Mclaughlin, MD, Maneka Puligandla, MS, Donna S Neuberg, ScD, Bruce Furie, MD, Robert C. Flaumenhaft, MD PhD

Blood (2018) 132 (Supplement 1): 985.

https://doi.org/10.1182/blood-2018-99-114946

Published: 2018

Journal Articles

Combination Treatment of Rituximab, Cyclophosphamide, and Dexamethasone for Warm Autoimmune Hemolytic Anemia

Hillel Bocian, MD, Caroline Piatek, MD, Howard A Liebman, MD, Casey L O'Connell, MD, Ilene Ceil Weitz, MD, Cage Saul Johnson, MD

Blood (2016) 128 (22): 4802.

https://doi.org/10.1182/blood.V128.22.4802.4802

Published: 2016

Journal Articles

Effects Of Dalteparin On The Heparanase/Syndecan-1 Axis In a Randomized Phase 2 Clinical Trial Of Patients With Treatment-Naive Multiple Myeloma

Sikander Ailawadhi, M.D., Howard A Liebman, MD, Susan Groshen, PhD, Denice D. Tsao-Wei, PhD, Leanne Rochanda, MS, Ibrahim Aldoss, MD, Casey O'Connell, MD, Teresa Wang, Christine Duran, Frederick Rickles, MD, FACP

Blood (2013) 122 (21): 5350.

https://doi.org/10.1182/blood.V122.21.5350.5350

Published: 2013

Journal Articles

D-Dimer Levels Among Cancer Patients with Unsuspected Pulmonary Embolism: Clinical Correlates and Relevance

Sonia Ali, MD, Elizabeth Dilday, Scott Tagawa, MD, Naveed H. Akhtar, MD, Howard A Liebman, MD, Pedram Razavi, MD, PhD, Leanne Rochanda, MS, David I Quinn, MD, PhD, Kathleen Seaton, Casey L. O'Connell, MD

Blood (2012) 120 (21): 1154.

https://doi.org/10.1182/blood.V120.21.1154.1154

Published: 2012

Journal Articles

Phase I/II Study of Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab in Relapsed Immune Thrombocytopenia,

Howard A Liebman, MD, Mansoor N Saleh, MD, James B Bussel, MD, Zale P Bernstein, MD, O George Negrea, MD, Anthony C Onyegbula, DO, Charles M Farber, MD, PhD, Heather Horne, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD

Blood (2011) 118 (21): 3302.

https://doi.org/10.1182/blood.V118.21.3302.3302

Published: 2011

Journal Articles

Heparin-PF4 Antibodies Are Frequent after Vascular Surgery, but Not a Frequent Cause of Graft Thrombosis or Thrombocytopenia.

Tamas Alexy, MD, PhD, Sony Tucker, MD, Soames Boyle, Leanne Rochanda, Douglas Hood, MD, Vincent L. Rowe, MD, Fred A. Weaver, MD, Howard A. Liebman, MD

Blood (2006) 108 (11): 1491.

https://doi.org/10.1182/blood.V108.11.1491.1491

Published: 2006

Journal Articles

An Unusual Form of Immune Thrombocytopenic Purpura Characertized by a Platelet Activating IgG Antibody.

Soames Boyle, Tamas Alexy, MD, PhD, Leanne Rhochanda, Howard A. Liebman, MD

Blood (2006) 108 (11): 1086.

https://doi.org/10.1182/blood.V108.11.1086.1086

Published: 2006

Journal Articles

A Fatal Bleeding Disorder Due to Antibody Mediated Acquired Factor X and Prothrombin Deficiency.

Leanne Rochanda, BA, Donald I. Feinstein, MD, Gregory J. del Zoppo, MD, Howard A. Liebman, MD

Blood (2006) 108 (11): 4072.

https://doi.org/10.1182/blood.V108.11.4072.4072

Published: 2006

Journal Articles

Ethnic and Serologic Differences Predict Clinical Behavior and Response in Immune Thrombocytopenia (ITP).

Sandeep K. Rajan, MBBS, Howard A. Liebman, MD, PhD

Blood (2005) 106 (11): 3985.

https://doi.org/10.1182/blood.V106.11.3985.3985

Published: 2005

Journal Articles

Chemotherapy-Induced Activation of Hemostasis: Dalteparin Suppresses Both Thrombin and Interleukin-6 Expression in Breast Cancer Patients Receiving Adjuvant Chemotherapy.

Ilene Ceil Weitz, MD, Howard A. Liebman, MD

Blood (2004) 104 (11): 3509.

https://doi.org/10.1182/blood.V104.11.3509.3509

Published: 2004

NARROW

Efficacy and Safety of Intravenous Efgartigimod 10 Mg/Kg in Adult Patients with Primary Immune Thrombocytopenia: Advance, a Phase 3 Clinical Trial in Progress

Targeting Protein Disulfide Isomerase with the Oral Flavonoid Isoquercetin Prevents Venous Thromboembolism in Advanced Cancer: Results of a Multi-Dose, Multi-Center, Phase II Clinical Trial (CATIQ Study)

Combination Treatment of Rituximab, Cyclophosphamide, and Dexamethasone for Warm Autoimmune Hemolytic Anemia

Effects Of Dalteparin On The Heparanase/Syndecan-1 Axis In a Randomized Phase 2 Clinical Trial Of Patients With Treatment-Naive Multiple Myeloma

D-Dimer Levels Among Cancer Patients with Unsuspected Pulmonary Embolism: Clinical Correlates and Relevance

Phase I/II Study of Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab in Relapsed Immune Thrombocytopenia,

Heparin-PF4 Antibodies Are Frequent after Vascular Surgery, but Not a Frequent Cause of Graft Thrombosis or Thrombocytopenia.

An Unusual Form of Immune Thrombocytopenic Purpura Characertized by a Platelet Activating IgG Antibody.

A Fatal Bleeding Disorder Due to Antibody Mediated Acquired Factor X and Prothrombin Deficiency.

Ethnic and Serologic Differences Predict Clinical Behavior and Response in Immune Thrombocytopenia (ITP).

Chemotherapy-Induced Activation of Hemostasis: Dalteparin Suppresses Both Thrombin and Interleukin-6 Expression in Breast Cancer Patients Receiving Adjuvant Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only